Antibiotics Market report outlines the evolution of Antibiotics Market by type, applications and identifies and assesses the best performing vendors in the market till 2028. Market reports present the revenue opportunities in the Market through 2023-2028, highlighting the market size and growth by technology, geography, vertical and end users

An exclusive Antibiotics Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa.

According to the latest study on ‘Antibiotics Market Forecast to 2028 - Covid-19 Impact and Global Analysis by Drug Class and Action Mechanism.’ The global antibiotics market was valued at US$ 44,111.31 million in 2020 and is projected to reach US$ 59,253.24 million in 2028; it is expected to grow at a CAGR of 4.0% during 2021–2028. The report provides trends prevailing in the global antibiotics market and the factors driving market along with those that act as hindrances.

Based on n drug class, the antibiotics market is segmented into Cephalosporin, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, and Others. The cephalosporin segment held the largest share of the market in 2020; however the fluoroquinolones segment is anticipated to register the highest CAGR of 5.3% in the market during the forecast period. Additionally, increasing incidence of pneumonia, bloodstream infections, and Urinary Tract Infections (UTI) is expected to increase the demand for carbapenems class of antibiotics in coming years. Moreover, the lower price of generic carbapenem-based antibiotics is expected to result in increased product adoption, thus compelling carbapenem-based antibiotic manufacturers to develop geographical footprint in lower and middle-income countries.


The prominent/emerging players in the Antibiotics Market research include:

Pfizer, Inc
Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals),
Abbott,
GlaxoSmithKline Plc,
Sanofi,
Novartis AG,
Bayer AG,
Bristol Myers Squibb Company,
Eli Lilly and Company,
Astellas Pharma
The growth of the market is attributed to some of the key factors, such as rising prevalence of bacterial infections and increasing development of generic drugs. However, challenges associated with tedious and expensive process of antibiotic development and due to coronavirus pandemic are expected to restraint the growth of the market during the forecast years.


About The Insight Partners:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876